Li 2006.
Methods | Six‐week, (likely) randomised study. |
Participants | In‐patients with depression according to CCMD‐III criteria. |
Interventions | Citalopram: 28 participants. Escitalopram: 28 participants. Citalopram dose‐range: 20‐40 mg/day. Escitalopram dose‐range: 10‐20 mg/day. |
Outcomes | Change in Hamilton Depression Rating Scale 17 Item (HDRS‐17) from baseline to endpoint, number of patients who responded to treatment. |
Notes | Waiting for translation from Chinese to English (only abstract available in English). |